8–9 JuneBasel, Switzerland

 

Host Sponsor

 

Welcome

...to Biotech Outsourcing Strategies Basel 2022

Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).

Since 2016 we are pleased to call Basel our home of our summer event. Located in the heart of Europe, Basel is a unique Life Science Ecosystem which we are proud to support. BOS Basel 2022 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing.

Covid Policy: click here to read the latest on Covid guidelines.


Badge QR Code: A QR code will be sent to you on Thursday 4th June and a reminder email sent with the same QR Code on Tuesday 7th June. Please have this QR code ready to present when you arrive at the venue so that your badge can be printed without delay. Contact Bio2Business if you have not received your badge given the schedule outlined herein.

Book your accommodation at BOS Basel 2022 by clicking here.

View Exhibition Floor plan

Important checklist for Sponsors

Important checklist for Exhibition Sponsors

Follow us on LinkedIn to see our latest announcements


Featured Speaker (BOS Basel 2022)

photo of Dr. Geert Van Raemdonck

The Power of Forced Degradation

Dr. Geert Van Raemdonck, Scientist HR-MS, AnaBioTec

ABSTRACT: Forced degradation (FD) studies are intended to increase the rate of chemical degradation or physical change of an active drug substance or drug product under stressed conditions. Such testing is undertaken to elucidate the intrinsic stability of the active (bio-)pharmaceutical ingredient and is part of the drug development process including formulation and packaging. Even though FD studies are performed at relatively harsh conditions within a short time period, the information gathered will provide highly relevant data of the drug substance to predict effects of real time environmental conditions.... Click here to Read More


Featured Company (BOS Basel 2022)

Logo for Fareva S.A.
Fareva S.A.
FAREVA employs 13,000 people distributed in 43 production sites located in 13 countries in EMEA and the Americas. 18 of the FAREVA sites (including the latest acquisitions) are dedicated to pharmaceutical activities.

FAREVA is a leading global pharmaceutical CDMO with industry leading capabilities...
View profile